Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) announced that its shares will be included in the MSCI Global Small Cap Indexes effective after the market close on November 24, 2025. This inclusion, compiled by Morgan Stanley Capital International, is designed to track the performance of smaller-capitalization companies in international markets.
According to the official announcement, the inclusion highlights investor recognition of Nanjing Leads Biolabs’ operating performance and potential for further development. Shareholders and potential investors are advised to exercise due care when trading the company’s shares. The board of directors reiterates that the inclusion in the MSCI Global Small Cap Indexes is a key milestone in the company’s ongoing growth and engagement with the global investment community.